UBRELVY is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults
Supplied as white to off-white capsule-shaped, biconvex tablets
Manufacturer # 00023650116
Brand UBRELVY®
Manufacturer Allergan Pharmaceutical
Country of Origin China
Application Calcitonin Gene-related Peptide (CGRP) Antagonist
Container Type Blister Pack
Dosage Form Tablet
Generic Drug Code 47478
Generic Drug Name Ubrogepant
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
NDC Number 00023650116
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Quantity 16 Tablets
Strength 100 mg
Supplier_ID 4384414
Type Unit Dose
UNSPSC Code 51142400
